Dr. Vannorsdall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1619 Creighton Rd
Ste 1
Pensacola, FL 32504Phone+1 850-444-4700Fax+1 850-444-7497
Education & Training
- Maine Medical CenterFellowship, Nephrology, 1999 - 2001
- Maine Medical CenterResidency, Internal Medicine, 1996 - 1999
- The Warren Alpert Medical School of Brown UniversityClass of 1996
Certifications & Licensure
- FL State Medical License 2018 - 2026
- AL State Medical License 2000 - 2024
- ME State Medical License 1998 - 2021
- NC State Medical License 2000 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
Publications & Presentations
PubMed
- 13 citationsAT1 receptor subtype mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation in the ratAdam Chodobski, Joanna Szmydynger-Chodobska, Mark D. Vannorsdall, Mel H. Epstein, Conrad E. Johanson
Regulatory Peptides. 1994-09-22 - 7 citationsA randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotensionMark D Vannorsdall, Srinivas Hariachar, L. Arthur Hewitt
Postgraduate Medicine. 2015-02-24 - 2 citationsPerioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis.Mark D. Vannorsdall, Yale S. Arkel, De Hui Ku, F. Lee Lucas, Jonathan Himmelfarb
Kidney International. 2003-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: